ABT-229 FOR POSTPRANDIAL DIGESTIVE SYMPTOMS/FUNCTIONAL DYSPEPSIA M96-586

ABT-229 用于餐后消化症状/功能性消化不良 M96-586

• 批准号: 6276578
• 负责人: JAMES M GORDON
• 金额: $ 1.83万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6276578
• 关键词: clinical research; drug screening /evaluation; gastrointestinal disorder chemotherapy; gastrointestinal sign /symptom; human subject; human therapy evaluation; longitudinal human study; macrolide antibiotics

The objectives of this study are to assess the safety and efficacy of long-term treatment (2 years) with ABT-229 on postprandial digestive symptoms in patients with functional dyspepsia.

本研究的目的是评估的安全性和有效性